Here we report a case of a patient with NSCLC adenocarcinoma, with ALK-rearrangement and bone, lymph nodal and choroidal metastases at diagnosis, who showed an impressive response to crizotinib in all sites. Here, ALK is linked to non-small cell lung carcinoma.